WO2008146835A1 - Composition destinée à favoriser la production d'équol dans le sang d'un sujet incapable d'en produire - Google Patents
Composition destinée à favoriser la production d'équol dans le sang d'un sujet incapable d'en produire Download PDFInfo
- Publication number
- WO2008146835A1 WO2008146835A1 PCT/JP2008/059789 JP2008059789W WO2008146835A1 WO 2008146835 A1 WO2008146835 A1 WO 2008146835A1 JP 2008059789 W JP2008059789 W JP 2008059789W WO 2008146835 A1 WO2008146835 A1 WO 2008146835A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- equol
- blood
- composition
- production
- promoting
- Prior art date
Links
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 title abstract 6
- 235000019126 equol Nutrition 0.000 title abstract 6
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 title abstract 6
- 239000008280 blood Substances 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000001737 promoting effect Effects 0.000 title abstract 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 abstract 4
- 235000007240 daidzein Nutrition 0.000 abstract 2
- 235000013861 fat-free Nutrition 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
- 235000008696 isoflavones Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
La présente invention concerne une composition efficace permettant la production d'équol dans le sang, destinée à être utilisée chez un sujet incapable d'en produire. Cette production peur être obtenue par métabolisation de daidzéine in vivo. L'invention concerne plus particulièrement une composition ou analogue destinée à favoriser la production d'équol dans le sang d'un sujet incapable d'en produire. Ladite composition se caractérise par le fait qu'elle comprend une isoflavone de type daidzéine etdes composants de lait solides non gras.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009516332A JP5517613B2 (ja) | 2007-05-28 | 2008-05-28 | エクオール非産生者用の血中エクオール産生促進組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007140538 | 2007-05-28 | ||
JP2007-140538 | 2007-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008146835A1 true WO2008146835A1 (fr) | 2008-12-04 |
Family
ID=40075072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/059789 WO2008146835A1 (fr) | 2007-05-28 | 2008-05-28 | Composition destinée à favoriser la production d'équol dans le sang d'un sujet incapable d'en produire |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5517613B2 (fr) |
WO (1) | WO2008146835A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020004568A1 (fr) | 2018-06-28 | 2020-01-02 | アサヒグループホールディングス株式会社 | Promoteur de production d'équol et composition alimentaire ou de boisson le comprenant pour favoriser la production d'équol |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007392A1 (fr) * | 1997-08-08 | 1999-02-18 | Otsuka Pharmaceutical Co., Ltd. | Compositions contenant de l'isoflavone |
WO2000064438A1 (fr) * | 1999-04-28 | 2000-11-02 | Novogen Research Pty Ltd | Traitement cardiovasculaire et osseux au moyen d'isoflavones |
JP2004222670A (ja) * | 2003-01-27 | 2004-08-12 | Katori Kaitaku Nogyo Kyodo Kumiai | 牛乳−豆乳混合液醗酵ヨーグルト及び牛乳−豆乳混合液醗酵ヨーグルトの製造方法 |
WO2005000042A1 (fr) * | 2003-06-30 | 2005-01-06 | Otsuka Pharmaceutical Co., Ltd. | Composition contenant une bacterie d'acide lactique qui produit un equol |
JP2005058088A (ja) * | 2003-08-12 | 2005-03-10 | Sanei Beans:Kk | 牛乳を含有する豆腐の製造方法及び豆腐 |
WO2005092121A2 (fr) * | 2004-03-19 | 2005-10-06 | Nestec S.A. | Apport d'ingredients fonctionnels |
-
2008
- 2008-05-28 WO PCT/JP2008/059789 patent/WO2008146835A1/fr active Application Filing
- 2008-05-28 JP JP2009516332A patent/JP5517613B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007392A1 (fr) * | 1997-08-08 | 1999-02-18 | Otsuka Pharmaceutical Co., Ltd. | Compositions contenant de l'isoflavone |
WO2000064438A1 (fr) * | 1999-04-28 | 2000-11-02 | Novogen Research Pty Ltd | Traitement cardiovasculaire et osseux au moyen d'isoflavones |
JP2004222670A (ja) * | 2003-01-27 | 2004-08-12 | Katori Kaitaku Nogyo Kyodo Kumiai | 牛乳−豆乳混合液醗酵ヨーグルト及び牛乳−豆乳混合液醗酵ヨーグルトの製造方法 |
WO2005000042A1 (fr) * | 2003-06-30 | 2005-01-06 | Otsuka Pharmaceutical Co., Ltd. | Composition contenant une bacterie d'acide lactique qui produit un equol |
JP2005058088A (ja) * | 2003-08-12 | 2005-03-10 | Sanei Beans:Kk | 牛乳を含有する豆腐の製造方法及び豆腐 |
WO2005092121A2 (fr) * | 2004-03-19 | 2005-10-06 | Nestec S.A. | Apport d'ingredients fonctionnels |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020004568A1 (fr) | 2018-06-28 | 2020-01-02 | アサヒグループホールディングス株式会社 | Promoteur de production d'équol et composition alimentaire ou de boisson le comprenant pour favoriser la production d'équol |
Also Published As
Publication number | Publication date |
---|---|
JP5517613B2 (ja) | 2014-06-11 |
JPWO2008146835A1 (ja) | 2010-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1800031I1 (hu) | Dioxa-biciklo[3.2.1.]oktán-2,3,4-triol származékok | |
ZA200809356B (en) | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith | |
HK1150731A1 (en) | The extract, tea drink and method of producing the same | |
WO2008023266A3 (fr) | Extrait de kiwi | |
WO2008130989A3 (fr) | Implants prothétiques | |
ZA200908722B (en) | Freeze-dried,aerated dairy or diary-substitute compositions and methods of making thereof | |
EP2190307A4 (fr) | Procédé de préparation d'une solution d'extrait végétal fermentée et solution d'extrait végétal fermentée ainsi obtenue | |
WO2010112494A3 (fr) | Boisson mélangée | |
EP2095820A4 (fr) | Lait fermenté destiné à améliorer et/ou à traiter la peau et son procédé de production | |
IL216238A0 (en) | 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof | |
WO2007100459A3 (fr) | Bandelettes chirurgicales | |
LT1928255T (lt) | Pieno produktų gamybos būdas, tuo būdu gauti produktai ir jų panaudojimas | |
WO2008020765A3 (fr) | Milieu d'imagerie comprenant du lactate et du pyruvate 13c hyperpolarisé | |
EP2137127A4 (fr) | Nouveaux procédés de production de 5-épi-beta -vétivone, de 2-isopropyl-6,10-diméthyl-spiro[4.5]déca-2,6-dién-8-one et de 2-isopropyl-6,10-diméthyl-spiro[4.5]déca-1,6-dién-8-one | |
EP2143784A4 (fr) | Composition comprenant une bactérie à acide lactique ayant une activité anti-allergique élevée et procédé de fabrication de la bactérie à acide lactique | |
WO2009146099A3 (fr) | Agents de contraste, procédés de préparation d’agents de contraste, et procédés d’imagerie | |
WO2010069335A3 (fr) | Diagnostic de l'endométrite | |
EP2127649A4 (fr) | Composition favorisant la bioabsorption de flavonoïdes, nourriture/boisson favorisant la bioabsorption de flavonoïdes grâce à cette composition, et procédé de production de la nourriture/de la boisson | |
WO2008146835A1 (fr) | Composition destinée à favoriser la production d'équol dans le sang d'un sujet incapable d'en produire | |
BRPI0919352A2 (pt) | Preparação de enzima para alimentos aglutinados e conformados, e, método para produzir um alimento aglutinado e conformado. | |
EP2499921A4 (fr) | Procédé de préparation de thés aromatisés utilisant du bois, et thés aromatisés préparés par celui-ci | |
WO2009077635A3 (fr) | Composition anti-inflammatoire, anti-oedémateuse et anti-érythémateuse, procédé permettant d'obtenir ladite composition et utilisations de celle-ci | |
EP2048134A4 (fr) | Dérivés de meptazinol à deux ligands et/ou leurs sels, leur procédé de préparation et leurs applications | |
HK1132432A1 (en) | Method of producing fermented milk drink or lactobacillus drink | |
WO2010142143A9 (fr) | Composé de pirfenidone, procédé de préparation et utilisation de celui-ci |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08764805 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009516332 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08764805 Country of ref document: EP Kind code of ref document: A1 |